Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Objective: To determine the standard of reporting of harms-related data, in randomised controlled trials (RCTs) according to the Consolidated Standards of Reporting Trials (CONSORT) statement extension for harms. Design: Systematic review. Data sources: The Cochrane library, Ovid MEDLINE, Scopus and ISI Web of Knowledge were searched for relevant literature. Eligibility criteria for selecting studies: We included publications of studies that used the CONSORT harms extension to assess the reporting of harms in RCTs. Results: We identified 7 studies which included between 10 and 205 RCTs. The clinical areas of the 7 studies were: hypertension (1), urology (1), epilepsy (1), complimentary medicine (2) and two not restricted to a clinical topic. Quality of the 7 studies was assessed by a risk of bias tool and was found to be variable. Adherence to the CONSORT harms criteria reported in the 7 studies was inadequate and variable across the items in the checklist. Adverse events are poorly defined, with 6 studies failing to exceed 50% adherence to the items in the checklist. Conclusions: Readers of RCT publications need to be able to balance the trade-offs between benefits and harms of interventions. This systematic review suggests that this is compromised due to poor reporting of harms which is evident across a range of clinical areas. Improvements in quality could be achieved by wider adoption of the CONSORT harms criteria by journals reporting RCTs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another important reason for data extraction errors might be the poor reporting of adverse events in randomised controlled trials, which have varying terminology, poorly defined categories, and diverse data sources. 30 31 32”
From Validity of data extraction in evidence synthesis practice of adverse events: reproducibility study (2022) · cites this paper as [31]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
Ioannidis, J. P. A., Evans, S. J. W., Gøtzsche, P. C., O'Neill, R. T., Altman, D. G., Schulz, K., Moher, D., & for the CONSORT Group* (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00009 · Cited by 1,593 · cited 2×
“(9) Subgroup Analysis – – – – NR NR 53 (43, 63) (10) Balanced discussion 5 (1, 17) 10i) 61 (50, 71) 10ii) 14 (7, 23) 10iii) 44 (33, 55) – 10a) 68 (60, 76) 10b) 61 (54, 70) 10c) 41 (34, 50) NR NR 83 (76, 91)”
MethodKirkham, J. J., Dwan, K. M., Altman, D. G., Gamble, C., Dodd, S., Smyth, R., & Williamson, P. R. (2010) · BMJ · doi:10.1136/bmj.c365 · Cited by 1,133
Self-citationMoher, D., Jones, A., Lepage, L., & for the CONSORT Group (2001) · JAMA · doi:10.1001/jama.285.15.1992 · Cited by 1,027 · cited 1×
“(5) Analysis of harms 0 (0, 9) 76 (66, 84) 6 (3, 10) 5a) 36 (28, 44) 5b) 7 (4, 13) 20 (3, 56) 12 (7, 19) 44 (34, 54)”
Plint, A. C., Moher, D., Morrison, A., Schulz, K., Altman, D. G., Hill, C., & Gaboury, I. (2006) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00557.x · Cited by 872
Turner, L., Shamseer, L., Altman, D. G., Weeks, L., Peters, J., Kober, T., Dias, S., Schulz, K. F., Plint, A. C., & Moher, D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000030.pub2 · Cited by 740
Cobo, E., Cortes, J., Ribera, J. M., Cardellach, F., Selva-O'Callaghan, A., Kostov, B., Garcia, L., Cirugeda, L., Altman, D. G., Gonzalez, J. A., et al. (2011) · BMJ · doi:10.1136/bmj.d6783 · Cited by 290 · cited 3×
“(5) Analysis of harms 0 (0, 9) 76 (66, 84) 6 (3, 10) 5a) 36 (28, 44) 5b) 7 (4, 13) 20 (3, 56) 12 (7, 19) 44 (34, 54)”
Reporting of Safety Results in Published Reports of Randomized Controlled Trials
(2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.306 · Cited by 287 · cited 2×
“CONSORT Recommendation % of trials (95% CI) that adhered to each recommendation (1) Title & Abstract 20 (9, 35) 12 (6, 20) 1i) 12 (6, 20)”
MethodFrequency and reasons for outcome reporting bias in clinical trials: interviews with trialists
Smyth, R. M. D., Kirkham, J. J., Jacoby, A., Altman, D. G., Gamble, C., & Williamson, P. R. (2011) · BMJ · doi:10.1136/bmj.c7153 · Cited by 220 · cited 3×
“(7) Number of patients analysed 17 (7, 32) 35 (25, 45) 18 (13, 24) 7a) 78 (72, 85) 7b) 40 (32, 48) NR 84 (77, 90) 74 (64, 82)”
Self-citationAre Peer Reviewers Encouraged to Use Reporting Guidelines? A Survey of 116 Health Research Journals
Hirst, A., & Altman, D. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035621 · Cited by 200
Cuervo, L. G., & Aronson, J. K. (2004) · BMJ · doi:10.1136/bmj.329.7456.1 · Cited by 152 · cited 3×
“(9) Subgroup Analysis – – – – NR NR 53 (43, 63) (10) Balanced discussion 5 (1, 17) 10i) 61 (50, 71) 10ii) 14 (7, 23) 10iii) 44 (33, 55) – 10a) 68 (60, 76) 10b) 61 (54, 70) 10c) 41 (34, 50) NR NR 83 (76, 91)”
BackgroundMethod
Cited by
Junqueira, D. R., Zorzela, L., Golder, S., Loke, Y., Gagnier, J. J., Julious, S. A., Li, T., Mayo-Wilson, E., Pham, B., Phillips, R., et al. (2023) · BMJ · doi:10.1136/bmj-2022-073725 · Cited by 281
Golder, S., Loke, Y. K., Wright, K., & Norman, G. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002127 · Cited by 277
Bougioukas, K. I., Liakos, A., Tsapas, A., Ntzani, E., & Haidich, A.-B. (2018) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.10.002 · Cited by 251
“As soon as there is reliance on published data we need to be aware of relevant scientific caveats when looking at data evaluating harms [65].”
BackgroundStevens, A., Shamseer, L., Weinstein, E., Yazdi, F., Turner, L., Thielman, J., Altman, D. G., Hirst, A., Hoey, J., Palepu, A., et al. (2014) · BMJ · doi:10.1136/bmj.g3804 · Cited by 242
Saini, P., Loke, Y. K., Gamble, C., Altman, D. G., Williamson, P. R., & Kirkham, J. J. (2014) · BMJ · doi:10.1136/bmj.g6501 · Cited by 209
Self-citation
Metadata
- Authors
- Hodkinson, A., Kirkham, J. J., Tudur-Smith, C., & Gamble, C.
- Affiliations
- Department of Biostatistics, MRC North West Hub for Trials Methodology Research, University of Liverpool, Liverpool, UK
- University of Liverpool (GB)
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2013-09
- Volume
- 3
- Issue
- 9
- Pages
- e003436
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC3787508
- OpenAlex
- W2112658951
- Cited by
- 111
- References
- 19
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 17 · 2023: 11 · 2022: 18 · 2021: 13 · 2020: 4 · 2019: 9 · 2018: 4 · 2017: 8 · 2016: 5 · 2015: 3 · 2014: 9
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- BMJ Open (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Funders
- York University
- Medical Research Council (G0800792, G1000397, G1000397-1/1)
- Topics
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Keywords
- harms reporting, adverse events, randomized controlled trials, reporting quality, benefit-harm balance, adverse event definitions, trial reporting guidelines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension. https://app.cochat.ai/papers/10.1136/bmjopen-2013-003436
- The paper
- Hodkinson, A., Kirkham, J. J., Tudur-Smith, C., & Gamble, C. (2013). Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension. BMJ Open. https://doi.org/10.1136/bmjopen-2013-003436
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
